Tag: ASX:SHL

The Fund focuses on Australian and United States large cap securities and ETFs, to deliver superior risk adjusted investment returns.

Our unique point of difference is our proprietary algorithm-based investment models which are designed to quantify market momentum and remove much of the emotional human bias in the investment decision-making process.

Two classes of units in the Fund are offered

Class A Units – which provide investment exposure to ASX listed securities and exchange traded funds.

Class B Units – which provide investment exposure to United States listed securities and exchange traded funds.

For more information, please call 1300 614 002.

Sonic Healthcare 1H21 Revenue $4.4bn, up 33% on the same time last year. EBITDA increased to $1.02bn and further growth of 5 – 10% into FY22 underpins our buy recommendation.

The balance sheet remains under-geared and we expect to see the company actively seeking M&A or JV opportunities.

SHL trades on a forward yield of 3.8%

Sonic Healthcare is looking oversold and we believe buying support will build within the $32.50 – $33.50 price range.

Sonic Healthcare is finding buying support and we’re likely to see an improvement in the short-term indicators as the stock price stabilizes near the $33.50 level. 

Sonic Healthcare is under Algo Engine buy conditions and is up 20% since being added to our model in February 2020.

We anticipate further EPS upgrades when Sonic reports 1HFY21 earnings on 18 Feb.

High single-digit earnings growth supports the 3.6% forward dividend yield.

Sonic Healthcare is finding buying support and we’re likely to see an improvement in the short-term indicators as the stock price stabilizes near the $32.50 level. 

Sonic Healthcare is finding buying support and we’re likely to see an improvement in the short-term indicators as the stock price stabilizes near the $32.50 level. 

Sonic Healthcare is finding buying support and we’re likely to see an improvement in the short-term indicators as the stock price stabilizes near the $32.50 level. 

Sonic Healthcare is finding buying support and we’re likely to see an improvement in the short-term indicators as the stock price stabilizes near the $32.50 level.